Stockholders’ Equity - Schedule of Summarizes the Stock Warrant Activity (Details) - Warrant [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Schedule of Summarizes the Stock Warrant Activity [Line Items] | ||
| Outstanding and exercisable, Warrants | ||
| Outstanding and exercisable, Weighted- Average Exercise Price Per Share | ||
| Granted, Warrants | 1,650,000 | 14,564,000 |
| Granted, Weighted- Average Exercise Price Per Share | $ 2.82 | $ 11.5 |
| Exercised, Warrants | ||
| Exercised, Weighted- Average Exercise Price Per Share | ||
| Forfeited, Warrants | (300,000) | |
| Forfeited, Weighted- Average Exercise Price Per Share | $ 11.5 | |
| Expired, Warrants | ||
| Expired, Weighted- Average Exercise Price Per Share | ||
| Outstanding, Warrants | 14,564,000 | |
| Outstanding, Weighted- Average Exercise Price Per Share | $ 11.5 | |
| Outstanding and expected to vest, Warrants | 15,914,000 | |
| Outstanding and expected to vest, Weighted- Average Exercise Price Per Share | $ 10.69 | |
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their other than stock options into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to other than stock options of the plan that expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to other than stock options that were terminated. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of other than options. No definition available.
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding and expected to vest, Warrants, including both vested and non-vested instruments. No definition available.
|
| X | ||||||||||
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest other than options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the other than stock option plan. No definition available.
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the other than stock option plan. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|